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INTRODUCTION
The genus Stachys comprises more than 450 species mainly 
distributed in warm-temperate regions of the Mediterranean basin 
and South-Western Asia. It represents one of the largest genera of 
Lamiaceae family [1], and the majority of the species belonging 
to this genus have been largely used in the traditional medicine. 
Stachys spp. are currently indicated as “Mountain tea” in several 
regions reflecting their principal use in infusions and decoctions. 
The genus Stachys is represented by annual or perennial herbs known 
for their interesting biological activities, i.e., anti-inflammatory [2], 
antispasmodic, sedative, and diuretic [3-5]. Several phytochemical 
components, which may be responsible of the biological activities, 
have been isolated from Stachys species, i.e., iridoids [6,7], 
phenylethanoid glycosides, flavonoids [8,9], acidic metabolites, 
polysaccharides, and terpenoids [10].
In Italy, the genus Stachys encompasses about 30 species and 
subspecies among which five species are considered endemic. 
Stachys alopecuros subsp. divulsa is one of these. This plant is 
characteristic of the mountain habitat of central Italy, being 
distributed only in a few regions (Umbria, Marche, Abruzzo, 
Lazio, and Molise) [11], on stony mountain pastures, scrubs, 
and screes, and preferring a calcareous, and dry soil up to 
2000 m a.s.l. S. alopecuros subsp. divulsa is a perennial plant 
with small, hirsute, and subcylindrical ascending stem. 
The opposite leaves are petiolate and densely hairy on the 
edge and along the veins. The flowers are gathered in small 
verticillasters held in a dense spike, yellow-white in color and 
blooming from June to August-September. The fruits, which 
are brown colored, are constituted by 4 ovate nuculae [12]. 
A previous study on this subspecies revealed the presence of 
phenypropanoid, saponin, and iridoid glycosides [6] which 
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Background: The phytochemical analysis of Stachys alopecuros subsp. divulsa, an endemic Italian species, has 
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are considered taxonomic markers for the genus and the 
family. In this paper, we reported a reassessment of the polar 
fraction constituents of this plant employing a patented 
method allowing the isolation of secondary metabolites of 
glycosidic nature.
MATERIALS AND METHODS
Plant Materials
The fresh plant materials (aerial parts) were collected at 
the flowering stage from a spontaneous population growing 
at the altitude of 1520 m a.s.l. in the territory of Pizzo Tre 
Vescovi, Marche, Italy (GPS coordinates: N 42°58′07″, and E 
13°14′10″). The botanical recognition was performed by one of 
us (F.M.) using available literature [12], and a representative 
specimen has been deposited in the Herbarium Universitatis 
Camerinensis (CAME, included in the online edition of 
Index Herbariorum c/o School of Biosciences and Veterinary 
Medicine, University of Camerino, Italy) under the codex 
CAME 24825. A sample of the studied species is also stored in 
our laboratory (code number SAD-30062012) for any further 
reference.
Instruments
NMR spectra were recorded on a Varian (now Agilent 
Technologies) Mercury 300 MHz instrument and/or on a 
Bruker Avance III 400 MHz instrument using D2O or CD3OD 
as deuterated solvents: The chemical shifts were expressed in 
ppm using the HDO signal to set the 1H-spectra acquired in 
D2O, while the internal solvent signal (m5) at 3.31 ppm was set 
as reference for the spectra in CD3OD.
MS spectra were performed on a Q-TOF MICRO spectrometer 
(Micromass, now Waters, Manchester, UK) equipped with an 
ESI source that operated in the negative and/or positive ion 
mode. The flow rate of sample infusion was 10 µL/min with 
100 acquisitions per spectrum. Data were analyzed using the 
MassLynx software developed by Waters.
Solvents having RPE purity grade were all purchased from 
Sigma-Aldrich or Carlo Erba Reagenti, silica gel 60 (70-230 
mesh ASTM) was purchased from Fluka.
Bidimensional NMR Experiments
Bidimensional spectra were performed on a Bruker Avance 
III 400 MHz instrument, operating at 9.4 T at 298 °K. 
Heteronuclear single quantum correlation (HSQC) 
experiments were acquired with a spectral width of 15 and 
250 ppm for the proton and carbon, respectively, an average 
1JC-H of 145 Hz, a recycle delay of 2 s and a data matrix of 4 
K × 256 points. Heteronuclear multiple bond correlation 
(HMBC) experiments were acquired with a spectral width 
of 15 and 250 ppm for the proton and carbon, respectively, a 
long-range coupling constant of nJC-H of 8 Hz, a recycle delay 
of 2 s and a data matrix of 4 K × 256 points.
Extraction and Isolation of Polar Compounds
A portion of 390.0 g of hair-dried plant materials was extracted 
with a mixture of ethanol 96% and distilled water in ratio 8:2 v/v 
(1.4 L). The whole was left in maceration for 5 days so that 
the metabolites could come into solution. The procedure was 
repeated three times to achieve an exhaustive extraction. The 
solutions, having a dark green coloration, were gathered together 
in a same flask and then filtered. After filtration, the organic 
solvent was eliminated under reduced pressure at a temperature 
below 45°C until a water suspension was obtained. Throughout 
this last part, pH was checked on normal litmus paper, and this 
was about 8. This step is necessary to verify that pH is not too 
acid, meaning not under the value of 5.5, because an extreme 
acidity at this step may cause secondary reactions with the 
formation of several artifacts coming from the hydrolysis of 
glycosides and esters present in the extract. The water suspension 
was then frozen to −20°C and later lyophilized at the same 
temperature to preserve temperature-sensitive compounds 
possibly present. The final dried crude extract obtained from 
this methodology weighed 86.7 g and was dark green colored.
Adsorption Chromatography
The crude extract (86.7 g) was subjected to an active charcoal 
treatment. It was adsorbed on a stationary phase consisting in a 
mixture of charcoal/celite/polyamide (10:1:1) (60.0 g) until no 
reaction to vanillin/HCl spray reagent occured according to a 
method reported in the patent by Ballero et al. [13]. The resulting 
suspension was then stratified on a Gooch funnel and eluted first 
with H2O to eliminate the mono- and disaccharides. These usually 
coelute with glycosidic constituents in silica gel chromatography 
and may interfere during the structure identification of the 
metabolites of interest. The desorption chromatography 
was conducted in steps using EtOH/H2O mixtures gradually 
increasing in EtOH percentages (30, 60, and 95%). In this manner, 
three fractions at different polarity were collected, and after freeze 
drying 23.9, 4.70, and 0.82 g of solids were recovered, from the 
30, 60 and 96% ethanolic elutions, respectively.
Silica Gel Column Chromatography
After a preliminary screening on thin layer chromatographys and 
paper chromatography, the separation step on silica gel column 
was first conducted on the 60% eluate because this showed the 
whole iridoid components and in comparable amount among 
them in respect to the other fractions. The 30% fraction, 
containing the more polar compounds, was partitioned in a 
second step. The 95% fraction did not contain iridoid glucosides 
and was not even considered.
The first chromatographic separation was performed on an 
aliquot of the 60% ethanolic elution for the weight of 4.0 g 
using 120.0 g of silica gel (ratio 1:30). The eluting system was a 
mixture of n-BuOH/H2O (82:18 v/v). From this chromatographic 
separation (Scheme 1) 11 compounds were isolated and 
identified by comparison with data reported in literature and/or 
by comparison with pure compounds available in our laboratory: 
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Verbascoside (10, 12.4 mg) [14] from the assembly of fractions 
8-15; stachysoside A (11, 11.2 mg) [8,15] in mixture with 
verbascoside (1:2) in the assembly of fractions 17-24; β-arbutin 
(9, 3.2 mg) [16] from the assembly of fractions 30-32; reptoside 
(6) [17] and 6-O-acetyl-ajugol (7) [18] in mixture in ratio 
1:1.5 (25.0 mg) from the assembly of fractions 43-45; ajugoside 
(1, 113.7 mg) [17,19] as pure compound from the assembly of 
fractions 53-54; 8-O-acetyl-harpagide (2, 1.0 g) [20] from the 
assembly of fractions 70-88; chlorogenic acid (8) [21] in mixture 
with 8-O-acetyl-harpagide (2) in ratio 1:2 (109.4 mg) from the 
assembly of fractions 95-112; harpagide (3) [22] and chlorogenic 
acid (8) in mixture 3:1 (48.3 mg) from the assembly of fractions 
118-122; allobetonicoside (4) and chlorogenic acid (8) in 
mixture 10:1 (29.1 mg) from the assembly of fractions 133-135; 
allobetonicoside (4, 100.7 mg) [23] as a pure compound from the 
assembly of fractions 144-163; 4′-O-galactopyranosyl-teuhircoside 
(5) [6] in mixture with allobetonicoside (4) in ratio 3:1 (24.7 mg) 
from the assembly of fractions 166-169.
A second chromatographic column was, instead, conducted 
on an aliquot of the 30% desorption solids (3.5 g). Similar 
compounds were isolated from this chromatographic step. 
In particular, harpagide (3), 8-O-acetylharpagide (2) as 
pure compounds, allobetonicoside (4) in mixture with 
4′-O-galactopyranosyl-teuhircoside (5), and ajugoside 
(1) occurring in traces (relative quantities not estimated). On 
the other hand, phenolic compounds as well as reptoside (6) 
and 6-O-acetyl-ajugol (7), were not found.
Spectral Data of the Isolated Compounds
Ajugoside (1): NMR data see Table 1; ESI-MS: m/z 412.80 
[M+Na]+.
8-O-acetylharpagide (2): 1H NMR (300 MHz, CD3OD) δ: 
6.40 (1H, d, J = 6.4 Hz, H-3), 6.08 (1H, br s, H-1), 4.92 (1H, 
d, J = 6.5 Hz, H-4), 4.60 (1H, d, J = 7.8 Hz, H-1′), 3.90 (1H, 
d, J = 11.8 Hz, H-6′a), 3.71 (2H, m, H-6′b; H-3′), 3.44-3.29 
(2H, m, H-4′; H-5′), 3.22 (1H, t like, J = 8.4 Hz, H-2′), 2.86 (1H, 
br s, H-9), 2.18 (1H, d, J = 15.1 Hz, H-7a), 2.02 (3H, s, CH3CO), 
1.94 (1H, dd, J = 15.2, 4.4 Hz, H-7b), and 1.45 (3H, s, H-10).
13C NMR (APT) (75 MHz, CD3OD) δ: 173.3 (CH3CO), 143.8 
(C-3), 106.8 (C-4), 99.8 (C-1′), 94.5 (C-1), 88.6 (C-8), 78.0 
(C-3′), 77.6 (C-5′), 77.4 (C-6), 74.4 (C-2′), 73.3 (C-5), 71.6 
(C-4′), 62.8 (C-6′), 55.4 (C-9), 46.0 (C-7), 22.5 (CH3CO), 
and 22.2 (C-10).
ESI-MS: m/z 429.04 [M+Na]+; m/z 835.19 [2M+Na]+.
Harpagide  (3) :  1H NMR (300 MHz,  CD 3OD) δ : 
6.32 (1H, d, J = 6.3 Hz, H-3), 5.74 (1H, br s, H-1), 4.95 (1H, d, 
J = 6.3 Hz, H-4), 4.58 (1H, d, J = 7.9 Hz, H-1′), 3.90 (1H, d, 
J = 12.2 Hz, H-6′a), 3.75-3.60 (2H, m, H-6′b; H-3′), 3.44-3.33 
(2H, m, H-4′; H-5′), 3.26-3.16 (1H, dd, J = 8.8, 8.2 Hz, H-2′), 
2.56 (1H, br s, H-9), 1.90 (1H, dd, J = 13.8, 4.6 Hz, H-7a), 
1.80 (1H, dd, J = 13.8, 3.6 Hz, H-7b), 1.25 (3H, s, H-10).
ESI-MS: m/z 387.14 [M+Na]+.
Allobetonicoside (4): 1H NMR (300 MHz, D2O) δ: 6.43 (1H, 
d, J = 6.3 Hz, H-3), 6.11 (1H, br s, H-7), 5.94 (1H br s, H-1), 
5.28 (1H, d, J = 8.3 Hz, H-1′′), 5.01 (1H, d, J = 6.3 Hz, H-4), 
4.75 (1H, d, J = 7.8 Hz, H-1′), 4.19 (1H, t, J = 2.6 Hz, H-9), 
3.93 (2H, m, H-6′a; H-6′′a), 3.83 (2H, m, H-6′b; H-6′′b), 3.70-
3.33 (8H, m, H-3′; H-3′′; H-4′; H-4′′; H5′; H-5′′; H-2′; H-2′′), 
and 2.28 (3H, s, H-10).
13C NMR (75 MHz, D2O) δ: 204.86 (C-6), 178.50 (C-8), 
144.09 (C-3), 127.77 (C-7), 102.69 (C-4), 98.89 (C-1′), 96.58 
(C-1′′), 92.25 (C1), 77.45 (C-5), 76.18 (C-5′), 75.60 (C-3′), 
73.57 (C-2′), 72.71 (C-4′′), 71.20 (C-2′′), 69.85 (C-3′′), 69.42 
(C-4′), 66.62 (C-4′′), 61.03 (C-6′′), 60.70 (C-6′), 54.85 (C-9), 
17.62 (C-10).
ESI-MS: m/z 528.73 [M+Na]+; m/z 544.69 [M+K]+.
4′-O-galactopyranosyl-teuhircoside (5): 1H NMR (300 MHz, 
D2O) δ: 6.43 (1H, d, J = 6.4 Hz, H-3), 6.13 (1H, br s, H-7), 
5.94 (1H, br s, H-1), 4.98 (1H, d, J = 6.4 Hz, H-4), 4.80 (1H, 
partially overlapped with solvent signal, H-1″), 4.73 (1H, d, 
J = 8.1 Hz, H-1′), 2.29 (3H, s, H-10).
ESI-MS: m/z 529.12 [M+Na]+.
Reptoside (6): 1H NMR (300 MHz, D2O) δ: 6.40 (1H, d, 
J = 6.5 Hz, H-3), 5.90 (1H, br s, H-1), 5.02 (1H, dd, J = 6.4, 
1.3 Hz, H-4), 4.75 (1H, d, partially obscured by the solvent 
signal, H-1′), 3.92 (1H, dd, J = 12.4, 1.9 Hz, H-6′a), 3.71 (1H, 
br d, J = 12.4 Hz, H-6′b), 3.26 (1H, dd, J = 8.3, 8.2 Hz, H-2′), 
2.65 (1H, br s, H-9), 2.04 (3H, s, CH3CO), 1.93 (2H, m, H-6a; 
H-7a), 1.71 (2H, m, H-6b; H-7b), 1.43 (3H, s, H-10).
Table 1: Complete NMR assignment of ajugoside (1) in D2O
Ajugoside (1), (400 MHz, D2O)
Position δ, 1H Multiplicity, J (Hz) δ, 13C (HSQC) HMBC 
Correlations
1 5.94 d, J=1.1 93.73 C5, C8, C1′
2 ‑ ‑ ‑ ‑
3 6.31 dd, J=6.4, 2.3 139.72 C1, C4, C5
4 4.89 ddd, J=6.4, 2.1, 1.1 103.46 C3, C5, C6, C9
5 2.85 br d, J=8.3 39.83 C3, C8
6 4.18 d, J=4.0 75.55 C7, C8
7a 2.25 d, J=15.4 46.74 C5, C6, C8, C9, C10
7‑b 2.18 dd, J=15.4, 4.3
8 ‑ ‑ 89.43 ‑
9 2.93 br d, J=8.5 47.48 C1, C5, C8
10 1.56 s 21.49 C7, C8, C9
Glucose
1′ 4.82 d, J=8.1 98.25 C1, C2′, C3′
2′ 3.33 dd, J=9.3, 8.1 72.73 C1′, C3′
3′ 3.56 m 75.65 C1′, C2′, C4′, C5′
4′ 3.44 m 69.65 C3′, C6′
5′ 3.52 m 76.26 C4′, C6′
6′a 3.98 dd, J=12.5, 2.2 60.77 C4′, C5′
6′b 3.78 dd, J=12.5, 6.0
CH3CO 2.08 s 174.14; 
21.73
C8, C=O
HSQC: Heteronuclear single quantum correlation, HMBC: Heteronuclear 
multiple bond correlation
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ESI-MS: m/z 413.04 [M+Na]+.
6-O-acetyl-ajugol (7): 1H NMR (300 MHz, D2O) δ: 6.34 (1H, 
dd, J = 6.4, 1.8 Hz, H-3), 5.50 (1H, d, J = 2.8 Hz, H-1), 
4.89 (1H, dd, J = 6.4, 2.8 Hz, H-4), 4.81 (1H, obscured by the 
solvent signal, H-6), 4.70 (1H, d, J = 8.0 Hz, H-1′), 3.90 (1H, 
dd, J = 12.1, 1.6 Hz, H-6′), 3.68 (1H, br d, J = 12.2 Hz, H-6′b), 
3.24 (1H, m, H-2′), 2.79 (1H, br t, J = 6.5 Hz, H-5), 2.34 (1H, 
dd, J = 7.9, 2.7 Hz, H-9), 2.12 (1H, br dd, J = 14.0, 6.5 Hz, 
H-7a), 2.08 (3H, s, CH3CO), 1.93 (1H, dd, J = 13.8, 8.6 Hz, 
H-7b), 1.38 (3H, s, H-10).
ESI-MS: m/z 413.04 [M+Na]+.
Chlorogenic acid (8): 1H NMR (300 MHz, CD3OD) δ: 7.56 (1H, 
d, J = 15.9 Hz, H-β′), 7.05 (1H, d, J = 1.9 Hz, H-2′), 6.96 (1H, dd, 
J = 8.2, 1.9 Hz, H-6′), 6.78 (1H, d, J = 8.2 Hz, H-5′), 6.26 (1H, d, 
J = 15.9 Hz, H-α′), 5.33 (1H, td, J = 9.1, 4.5 Hz, H-3), 4.17 (1H, 
dt, J = 6.2, 3.2 Hz, H-4), 3.73 (dd, J = 8.5, 3.1 Hz, H-5), 2.27-2.13 
(2H, m, H-2a; H-6a), 2.13-1.98 (2H, m, H-2b;H-6b).
ESI-MS: m/z 377.30 [M+Na]+.
β-arbutin (9): 1H NMR (300 MHz, CD3OD) δ: 7.07 (2H, d, 
J = 8.6 Hz, H-3, H-5), 6.69 (2H, d, J = 8.6 Hz, H-2, H-6), 
4.95 (1H, partially obscured by HDO signal, H-1′), 3.96-3.79 (m, 
overlapped glucose protons), 3.77-3.54 (m, overlapped glucose 
protons), 3.18 (1H, br t, J = 7.9 Hz, H-2′).
ESI-MS: m/z 311.22 [M+K]+.
Verbascoside (10): 1H NMR (300 MHz, CD3OD) δ: 7.59 (1H, d, 
J = 15.9 Hz, H-β′′), 7.05 (1H, d, J = 1.4 Hz, H-2′′), 6.96 (1H, dd, 
J = 8.2, 1.4 Hz, H-6′′), 6.78 (1H, d, J = 8.2 Hz, H-5′′), 6.69 (1H, 
br s, H-2′), 6.68 (1H, d, J = 8.0 Hz, H-5′), 6.56 (1H, dd, J = 8.0, 
1.6 Hz, H-6′), 6.28 (1H, d, J = 15.9 Hz, H-α′′), 5.19 (1H, d, 
J = 0.9 Hz, H-1′′′), 4.38 (1H, d, J = 7.8 Hz, H-1), 2.79 (2H, br 
t, J = 7.3 Hz, H-β′), 1.09 (3H, d, J = 6.2 Hz, H-6′′′).
ESI-MS: m/z 623.19 [M-H]-; m/z 647.12 [M+Na]+.
Stachysoside A (11): 1H NMR (300 MHz, CD3OD) δ: 7.60 (1H, 
d, J = 15.6 Hz, H-β′′[caff.]), 7.06 (1H, br s, H-2′′), 6.98 (1H, br d, 
J = 8.5 Hz, H-6′′), 6.78 (1H, d, J = 8.5 Hz, H-5′′), 6.70 (1H, br s, 
H-2′), 6.68 (1H, d, J = 8.0 Hz, H-5′), 6.57 (1H, br d, J = 8.1 Hz, 
H-6′), 6.28 (1H, d, J = 15.6 Hz, H-α′′), 5.42 (1H, br s, H-1′′′), 
4.43 (1H, d, J = 7.9 Hz, H-1), 4.31 (1H, d, J = 7.2 Hz, H-1′′′′), 
2.81 (2H, d, J = 7.1 Hz, H-β′), 1.16 (3H, d, J = 6.0 Hz, H-6′′′).
ESI-MS: m/z 755.20 [M-H]-; m/z 779.16 [M+Na]+.
RESULTS
The reassessment of the glycosidic fraction of S. alopecuros 
subsp. divulsa allowed the isolation of several compounds. 
The majority of them were iridoids, followed by a phenolic 
glucoside, two phenylethanoid glycosides, and a caffeoylquinic 
acid. They were identified as ajugoside (1), 8-O-acetylharpagide 
(2), harpagide (3), allobetonicoside (4), 4′-O-galactopyranosyl-
teuhircoside (5), reptoside (6), 6-O-acetyl-ajugol (7) [Figure 1] 
for the iridoid glycosides constituents, and as chlorogenic 
Figure 1: Iridoids from Alopecurus alopecuros subsp. divulsa
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acid (8), β-arbutin (9), verbascoside (10), and stachysoside A 
(11) [(2-(3,4-dihydroxyphenyl)ethyl-O-α-L-arabinopyranosyl-
(1→2)-O-6-deoxy-β-L-mannopyranosyl-(1→3)-4-O-
[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]-β-D-
glucopyranoside] [Figure 2] for the phenolic compounds. The 
presence of previously identified iridoid glycosides (2-5) has 
been confirmed, together with ajugoside (1), reptoside (6), 
and 6-O-acetyl-ajugol (7) which resulted to be new iridoid 
components for this species. Among the phenolic constituents, 
chlorogenic acid (8), β-arbutin (9), and stachysoside A (11) were 
isolated for the first time from the studied species [Figure 1].
DISCUSSION
Chemosystematic Implications of Isolated Compounds
The identified iridoids have all chemosystematic relevance. In 
particular, 2 and 3 are considered family markers, 4 is characteristic 
of the section Betonica, and 5 has never been reported in other 
Figure 2: Phenolics from Alopecurus alopecuros subsp. divulsa
Figure 3: 1H-NMR spectrum of ajugoside (1)
Stachys species so that it may be regarded as a chemotaxonomic 
marker at a subspecific level. Reptoside (6) resulted to be a rare 
metabolite in the Stachys genus because its occurrence has been 
reported only in a few species, namely Betonica officinalis (syn. of 
Stachys officinalis) [23] and S. macrantha [24]. 6-O-acetyl-ajugol 
(7), is also a rare metabolite in the Lamiaceae family since it has 
been found only in Leonurus persicus so far [18]. It is also worth 
of mention the presence of ajugoside (1) and reptoside (6) which 
are iridoids widely distributed in the species of the Ajugoideae 
subfamily. In fact, 1 was mainly reported in the Ajuga genus 
(e.g. Ajuga tenorei and Ajuga chamaepitys) [25,26], although 
its presence was also signaled in a few Lamioideae species as 
Melittis melissophyllum subsp. melissophyllum [19] and species 
of the genera Stachys and Sideritis. The occurrence of 1 in the 
Stachys genus is limited to a few species such as B. officinalis 
(syn. of S. officinalis (L.) Trevis.) [2], S. macrantha [24], S. alpina 
[2], Stachys germanica [2,27] and Stachys recta [2], and it has 
been identified also in the taxonomically related Sideritis genus 
like for instance in Sideritis romana [28], and Sideritis perfoliata 
subsp. perfoliata [29].
Considering their occurrence, compounds (1) and (6) may 
represent chemosystematic traits of proximity between 
Lamioideae and Ajugoideae subfamilies. The identification 
of 1 has been carried out by extensive NMR analysis on both 
mono - [Figures 3 and 4] and bidimensional [Figures 5 and 6] 
experiments since the assignment of resonances was not 
immediate for several signals, in particular for protons 
in 5, 6 and 9 positions on the iridoid skeleton as well as 
for protons in 3′ and 5′ positions of the glucose moiety 
[Figures 3 and 4].
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Figure 4: 13C-NMR spectrum of ajugoside (1)
Figure 5: Heteronuclear single quantum correlation spectrum of ajugoside (1)
In particular, the resonance of H-6 was readily visible in the 
proton spectrum at 4.18 ppm, but the corresponding carbon 
signal was very near to a glucose carbon resonance and has 
been assigned by the direct HSQC correlation [Figure 5] 
with the signal resonating at 75.55 ppm. On the contrary, the 
assignment of protons and carbons in the position 5 and 9 was 
not immediate, and several long range correlations resulted to 
be crucial for discriminating the resonances of these nuclei. 
The signals relative to the positions 5 and 9 present resonances 
in the proton spectrum at 2.93 and 2.85 ppm, both as broad 
signals, and the study of the coupling constants gave no help 
for the structure elucidation. In the HSQC spectrum, a direct 
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correlation between the proton signal at 2.93 ppm and the carbon 
resonating at 47.48 ppm was recorded as well as the correlation 
between the proton at 2.85 and the carbon at 39.83 ppm. This 
permitted to assign the respective carbons signals. In the HMBC 
experiments, [Figure 6] the only diagnostic correlation which 
permitted to differentiate the positions 5 and 9 was a long range 
correlation between H-3 (6.31 ppm) and the carbon resonating 
at 39.83 ppm, which could be assigned to C-5 of the iridoid 
skeleton, since almost all the proton signals correlated with both 
the carbons at 39.83 and 47.48 ppm. In fact, H-3 is relatively far 
from C-9, and this kind of signal could not be visualized with 
the coupling constant of 8 Hz set in the experiment. Using the 
HMBC correlations, it was also possible to differentiate the 
positions 3′ and 5′ on the glucopyranose unit. In particular, 
the resonances of the positions 1′, 2′, 4′, and 6′ (98.25, 72.73, 
69.65, and 60.77, respectively) were readily assignable to the 
saccharidic moiety, while the signals relative to 3′ and 5′ might 
be differentiated on the basis of their correlation with near 
nuclei [Figures 5 and 6].
More specifically, from HMBC experiments the following long-
range correlations were recognized: Between the proton signal at 
3.33 ppm (H-2′) and the carbon at 75.65 (C-3′); the proton at 
3.34 ppm (H-4′) with carbons at 76.26 (C-5′) and 75.65 (C-3′); the 
protons at 3.98-3.78 (H-6′) with carbon resonating at 76.26 (C-5′). 
The latter correlation is particularly crucial for the assignation 
of the C-5′ position because H-6′ cannot correlate with C-3′. 
The complete assignments of resonances are reported in Table 1.
Chlorogenic acid (8) has been isolated for the first time from 
S. alopecuros subsp divulsa, although it has been already found 
in several Stachys species as S. tymphaea [8], S. lanata [30], 
S. officinalis [31], S. recta [32], S. byzantina, S. iberica subsp. 
iberica var. densipilosa [33], and S. glutinosa [34]. In most of 
these species, the chlorogenic acid (8) resulted to be the main 
polyphenolic component occurring in the polar fraction just 
like in this case [Figure 2].
Figure 6: Heteronuclear multiple bond correlation spectrum of ajugoside (1)
Scheme 1: Chromatographic steps on 60% ethonolic fraction and 
elution order of components
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Furthermore, β-arbutin (9) was a metabolite identified for the 
first time in this species. It proved to be a quite rare compound 
in the Stachys genus since its presence has been signaled only in 
S. germanica subsp. salviifolia [7]. The presence of verbascoside 
(10), a quite common phenyletanoid glycoside (PhGs) in 
Lamiaceae, has been confirmed, while stachysoside A (11), 
also known with the name lavandulifolioside, resulted to be 
as a new constituent of S. alopecuros subsp. divulsa. PhGs are 
compounds with a chemosystematic relevance in Asterids since 
their cooccurrence with iridoid glycosides, as in the studied 
case, has been largely confirmed [35]. The presence of 11 was 
noteworthy since it is not an ubiquitous compound, especially 
in the Stachys genus where it has been recognized only in a 
few species such as S. lavandulifolia [36], S. sieboldii [15], and 
S. tymphaea [8]. This compound resulted to be a constituent 
of other systematically related genera such as Leonurus [37,38], 
Lagochilus [39], and Sideritis [40].
Bioactivities of Isolated Compounds
The isolated compounds are responsible for several 
interesting activities. In particular, iridoids are known to 
possess anti-inflammatory properties. Harpagide (3) and its 
derivatives are constituents of Harpagophytum procumbens 
D.C. (Pedaliaceae), a medicinal plant native to Namibia 
and commonly known as Devil’s Claw. This plant has been 
widely studied for its anti-inflammatory and analgesic effects 
which were demonstrated also in in vivo models, principally 
in rats [41-43]. The target of harpagide and its derivatives 
is represented by the inhibition of COX-2, an enzyme 
deputed to the production of the proinflammatory mediators 
prostaglandins and leukotrienes. Recent docking studies 
have demonstrated that harpagide is a selective inhibitor of 
COX-2, binding its active site with a strong interaction and 
being stabilized by 10 hydrogen bonds [44]. This confirms, 
on a molecular base, the observed anti-inflammatory and 
analgesic actions exerted by plants containing harpagide 
derivatives. Beside the anti-inflammatory action, harpagide 
(3) results a modulator of Tumor necrosis factor α (TNF-α) 
secretion and induces the expression of several proteins 
involved in cell migrations. It shows an immunomodulatory 
effect facilitating the leukocyte migration in the inflamed 
tissues [45]. The latter is a very important role because the 
inflammatory process is not only responsible of pain and loss 
of function but it is also involved in the onset and progression 
of degenerative diseases, including cardiovascular disorders 
and cancer. In a similar way, 8-O-acetyl harpagide (3) also 
showed a dose-related inhibition of leukocyte adhesion and 
transmigration in a system based on human umbilical vein 
endothelial cells, and human monocytic leukemia cell line 
THP-1 previously activated with TNF-α [46].
It was also studied, the protective effect of harpagide (3) against 
bone loss in ovariectomized mouse model. It resulted that this 
iridoid stimulates the differentiation and maturation processes 
of osteoblasts and this conducted to an overall improved bone 
properties with the recovery of mineral density. The reduced 
levels of biochemical markers of bone loss in the serum of 
treated mice (alkaline phosphatase, osteocalcin, and C-terminal 
telopeptide) seems to be the major mode of action of harpagide 
(3) [47], thus demonstrating the potential role of this iridoid 
also in the prevention and treatment of age-dependent bone 
osteoporosis diseases.
From recent studies on iridoid activities, 8-O-acetylharpagide 
(2) and ajugoside (1) resulted to be useful compounds in the 
treatment of diabetes mellitus since they were able to stimulate 
the cellular glucose intake and lower the glucose blood level [38]. 
Another target of iridoids for the antidiabetic activity is 
represented by the inhibitory action, verified by docking studies, 
on glycogen phosphorylase-a [48]. In fact, several plant species 
rich in iridoids have been largely used in traditional medicine 
for the treatment of diabetes, e.g., Scrophularia deserti Del. [49] 
and Leonurus sibiricus L. [38].
The phenolic fraction of S. alopecuros subsp. divulsa was mainly 
composed by chlorogenic acid (8), which is also endowed with 
interesting activities [34]. This caffeoylquinic acid is a strong 
antioxidant [50], a good wound healer if topically applied on 
excisions [51] and has also antiviral action toward hepatitis B 
virus [52]. Furthermore, it shows antiproliferative action [34], 
inhibits carcinogenesis, strongly reduces the risk of cardiovascular 
diseases and significantly improves the metabolism of glucose. 
The latter is the main reason why it has recently drawn the 
attention from nutritionists for its high antidiabetic and anti-
obesity properties [53]. The antioxidant and enzyme inhibitory 
activities in respect to acetylcholineserase, butrylcholinesterase, 
and α-amylase [33] may have a protective role in neurologic 
diseases such as Alzheimer’s disease, and metabolic disorders 
as diabetes mellitus.
The other phenolic constituents also have interesting biological 
activities. In fact, β-arbutin (9) possesses a strong antibacterial 
activity and is traditionally used for urinary tract infections [54]. 
It is also a tyrosinase inhibitor and is employed as a skin whitener 
because it inhibits the melanin synthesis [55].
The phenylethanoid glycoside verbascoside (10) shows an 
antibacterial action especially toward S. aureus [56] and anti-
inflammatory activity [57]. More recently, in an in vivo study, it 
resulted to be an inhibitor of xanthine oxidase which reduced 
uric acid concentration in rat serum. These results may suggest 
its potential use to treat hyperuricemy [58].
For what concerns the activity of stachysoside A (11), in 
literature there are mainly studies conducted on extracts 
obtained from species containing this compound. In this 
context, it is noteworthy the neuroprotective effects observed in 
S. sieboldii tuber extract which resulted to improve the memory 
dysfunction associated with vascular dementia or Alzheimer’s 
disease in induced-ischaemia in mice [59]. The presence of 
antioxidant components resulted to have a primary role in 
neuroprotection and PhGs are well-known antioxidants. Species 
belonging to Leonurus genus, all containing (11) together with 
iridoids, have been largely used in the traditional Mongolian 
medicine for the treatment of diabetes mellitus [38] and in the 
treatment of neurological disorders such as anxiety, depression, 
and nervousness [37].
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CONCLUSIONS
This phytochemical study on the endemic S. alopecuros subsp. 
divulsa shed light on three additional iridoid glucosides together 
with chlorogenic acid (8), β-arbutin (9), verbascoside (10), 
and stachysoside A (11) in the phenolic fraction. The presence 
of verbascoside has been already reported, while the other 
phenolics were identified for the first time in the studied 
species. The monoterpene glycoside pattern owned by S. 
alopecuros subsp. divulsa has been disclosed with respect 
to literature data, showing the presence of ajugoside (1), 
reptoside (6), and 6-O-acetyl-ajugol (7). All these compounds 
have chemosystematic relevance. In particular, 1 and 6 may 
represent a metabolic connection between Lamioideae and 
Ajugoideae subfamilies while 7 is a quite uncommon compound 
in the Lamiaceae family since it has been found only in L. 
persicus so far. We also took advantage of this occasion to 
report a complete NMR assignment for compound 1. From a 
therapeutic perspective, the isolated compounds are known for 
their antioxidant, antiproliferative, anti-inflammatory, analgesic, 
immunomodulatory, neuroprotective, and antidiabetic actions. 
Their occurrence in the studied species provides evidence of a 
possible natural source of bioactive compounds for extractive 
purposes but also of its potential as a natural remedy of medical 
importance.
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